Connexin-based signaling and drug-induced hepatotoxicity

Michaël Maes1, Mathieu Vinken1

  • 1Department of In Vitro Toxicology and Dermato-Cosmetology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.

Insights

Connexins are vital for liver health and can be harmed by toxic drugs. This study examines how common hepatotoxic drugs affect connexin channels, impacting liver function and toxicology.

Area of Science:

  • Hepatology
  • Cellular Biology
  • Toxicology

Background:

  • Connexins and their channels are crucial for maintaining liver homeostasis.
  • These communicative structures are often implicated in drug-induced liver injury.
  • Understanding connexin roles is vital for assessing drug safety.

Purpose of the Study:

  • To provide an overview of connexin channel properties in the liver.
  • To discuss the effects of specific hepatotoxic drugs on connexin signaling.
  • To highlight the relevance of connexin research in clinical and in vitro toxicology.

Main Methods:

  • Literature review on connexin structure, regulation, and function in the liver.
  • Analysis of documented effects of acetaminophen, hypolipidemic drugs, phenobarbital, and methapyriline on connexin signaling.
  • Discussion of the implications for toxicological assessments.

Main Results:

  • Connexin channels exhibit specific structural, regulatory, and functional characteristics in hepatocytes.
  • Hepatotoxic drugs like acetaminophen and phenobarbital demonstrably alter connexin-mediated signaling.
  • Drug-induced changes in connexin function contribute to liver toxicity.

Conclusions:

  • Connexin channels are key targets for hepatotoxic drug actions.
  • Altered connexin signaling is a significant mechanism in drug-induced liver toxicity.
  • Connexin research is essential for advancing clinical and in vitro toxicology.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
51
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
62
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
80
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
58
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.0K
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
67